Bloodstream Infection Testing Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-20　·　153 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 5,000 Mn
2033 年預估規模: USD 8,025 Mn
年複合成長率 CAGR: 7%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-20頁數 153報告編號 CMI1727

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Bloodstream Infection Testing Market , By Product Type (Instruments, Reagents, and Others), By Technology (Conventional Testing and Non-Conventional Testing), By Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), By End User (Hospitals, Independent Diagnostics Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

Blood stream infection is a condition in which the blood is detected with bacterial, fungal, or any other infection. This condition normally occurs when the infection enters the blood stream of any part of body through wound, injection or during any surgical procedures. This infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult, owing to its common symptoms (such as chills, fever, diarrhea, vomiting, and others), thereby testing is mandatory for detection of infections in blood. Market Dynamics Increasing prevalence of infections such as abdominal infections, dental infections, kidney and urinary infection, and chronic diseases drives the market growth. According to the World Health Organization (WHO), in 2016, over 30 million people are affected by sepsis worldwide, annually, leading to 6 million deaths. Moreover, increasing R&D investments related to bloodstream infection testing is also expected to boost the market growth. Moreover, high incidences of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with growing awareness about hygiene is also expected to boost the global bloodstream infection testing market growth. According to World Health Organization, at the end of 2017, approximately 36.9 million people living with HIV and 1.8 million people becoming newly ininfected in 2017 globally. However, the high diagnostic costs and insufficiency medical reimbursement may hinder the market growth. Key features of the study • This report provides in-depth analysis of the bloodstream infection testing market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global bloodstream infection testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans. • Key companies covered as a part of this study include, BioMérieux SA, Becton, Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, Siemens Healthcare. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global bloodstream infection testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bloodstream infection testing market Market Segmentation • Product Type Insights (Revenue, USD Mn, 2026 - 2033) o Instruments o Reagents & Consumables o Others • Technology Insights (Revenue, USD Mn, 2026 - 2033) o Conventional Testing o Non-Conventional Testing • Test Type Insights (Revenue, USD Mn, 2026 - 2033) o Conventional Blood Culture Tests o PCR Method o Nucleic Acid Testing o Mass Spectroscopy o Point-Of-Care Testing • End User Insights (Revenue, USD Mn, 2026 - 2033) o Hospitals o Independent Diagnostics Centers o Others • Regional Insights (Revenue, USD Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  North Africa  Central Africa  South Africa • Key Players Insights o BioMérieux SA o Becton o Dickinson and Company o AB Sciex o IRIDICA o Abbot Laboratories o Cepheid Inc. o C. R. Bard, Inc. o F. Hoffmann-La Roche AG o Nanoshpere o Dade Behring o AdvanDX o Siemens Healthcare

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Global Bloodstream Infection Testing Market, By Product Type  Global Bloodstream Infection Testing Market, By Technology  Global Bloodstream Infection Testing Market, By Test Type  Global Bloodstream Infection Testing Market, By End User  Global Bloodstream Infection Testing Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trend 4. Global Bloodstream Infection Testing Market, By Product Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Instruments  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Reagents & Consumables  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 5. Global Bloodstream Infection Testing Market, By Technology, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Conventional Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Non-Conventional Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 6. Global Bloodstream Infection Testing Market, By Test Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Conventional Blood Culture Tests  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o PCR Method  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Nucleic Acid Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Mass Spectroscopy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Point-Of-Care Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 7. Global Bloodstream Infection Testing Market, By End User, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Independent Diagnostics Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 8. Global Bloodstream Infection Testing Market, By Region, 2026 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o BioMérieux SA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Becton  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Dickinson and Company  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o AB Sciex  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o IRIDICA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbot Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Cepheid Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o C. R. Bard, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o F. Hoffmann-La Roche AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Nanoshpere  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Dade Behring  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o AdvanDX  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Siemens Healthcare  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 10. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. References and Research Methodology o References o Research Methodology o About us

提及公司

BioMérieux SABectonDickinson and CompanyAB SciexIRIDICAAbbot LaboratoriesCepheid Inc.C. R. Bard, Inc.F. Hoffmann-La Roche AGNanoshpereDade BehringAdvanDXSiemens Healthcare

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們